Effect of Shotblocker in Reducing Intramuscular Injection Pain in Adult Patients
ConditionPatients Above 18 Years
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYağmur SÜRMELİ
About this trial
This randomized, double-blind study aimed to determine the effect of ShotBlocker on IMI pain in adult patients who received diclofenac sodium and metamizole sodium as IMI in the emergency department. The main question(s) it aims to answer are as follows:
• \[Is there a difference between the pain score averages between the intervention group and the control group after ShotBlocker? Participants \[Participants in both groups are individuals who applied to the emergency department and received IM injections according to the doctor\'s order.\] If there is a comparison group: Researchers will make a comparison with the control group.
Eligibility criteria
Qualifiers
Patients aged 18 and over who speak Turkish,
Who have signed the informed consent form,
Who are admitted to the emergency room for prescription drug use or who are planned to use diclofenac sodium and metamizole sodium as IMI upon the directive of the emergency room physician will constitute.
Disqualifiers
Pregnant women,
Those with psychiatric disorders,
Those with hearing or vision problems,
Those who applied to the red area of the emergency room,
Trial design
Treatments tested in this trial
- ShotBlocker
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov